Both Wegovy and Ozempic contain semaglutide, but they are licensed for different indications Wegovy is specifically approved for weight management at a maintenance dose of 2.4 mg weekly, while Ozempic is licensed for type 2 diabetes at doses up to 2 mg weekly
Mochi Healths Public Response In its own public statement, Mochi Health framed the lawsuit as part of a broader pattern of large pharmaceutical companies challenging smaller, more affordable healthcare alternatives
Advise patients that substantial or rapid weight loss can increase the risk of gallbladder disease, but that gallbladder disease may also occur in the absence of substantial or rapid weight loss
Satteles Rapid Weight Loss Centers have produced
A 5-unit air bubble in a 25-unit draw means you are only injecting 20 units of actual solution
But remember: Mounjaro has significantly more evidence base, while Retatrutide data is based on smaller studies